98%
921
2 minutes
20
Objectives: To assess the accuracy and costs of laboratory tests in Kampala, Uganda.
Methods: A random selection of 78 laboratories tested external quality assurance samples at market rates. There were 40 moderate- to high-complexity and 38 low-complexity laboratories. Four percent (3/78) of these laboratories were accredited and 94% (73/78) were private. The 40 moderate- to high-complexity laboratories performed malaria blood smear, urine human chorionic gonadotropin (hCG), human immunodeficiency virus (HIV), syphilis, glucose, and three-panel tests: CBC, liver function tests, and kidney function tests. The 38 low-complexity laboratories performed malaria blood smear, urine hCG, and syphilis testing only. Hematology, HIV, syphilis, and malarial proficiency testing samples were prepared by accredited laboratories in Kampala. All other samples were provided by the Royal College of Pathologists of Australia.
Results: 77.1% of all results were accurate (met target values). It varied widely by laboratory (50%-100%), test identity (malaria blood smear, 96%; serum urea nitrogen, 38%), and test type (quantitative: 66% [31%-89%], qualitative: 91% [68%-97%]). Test prices varied by up to 3,600%, and there was no correlation between test cost and accuracy (r2 = 0.02).
Conclusions: There were large differences in accuracy and price across laboratories in Kampala. Price was not associated with quality.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/ajcp/aqy017 | DOI Listing |
Lancet HIV
September 2025
Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK; Botswana Harvard Health Partnership, Gaborone, Botswana.
Background: HIV-associated cryptococcal meningitis case fatality remains greater than 25%. Co-prevalent infections might contribute to poor outcomes. We aimed to ascertain the prevalence and the clinical significance of Epstein-Barr virus (EBV) and cytomegalovirus co-infections in patients with cryptococcal meningitis to guide potential therapeutic interventions.
View Article and Find Full Text PDFBMC Health Serv Res
September 2025
Rakai Health Sciences Program, P.O. Box 279, Kalisizo, Uganda.
Background: Hemoglobin estimation (Hb) is the most requested hematology test, especially among pregnant/postnatal women and people living with HIV (PLHIV). In Uganda, several point-of-care (POC) Hb testing devices are currently used and performance may be affected by multiple factors. This study evaluated the diagnostic and analytic performance of four Hb POC devices.
View Article and Find Full Text PDFBiol Res
September 2025
Department of Biochemistry and Systems Biology, School of Biosciences, College of Natural Sciences, Makerere University, P.O. Box 7062, Kampala, Uganda.
Background: Sickle cell disease (SCD) is characterised by chronic oxidative stress. However, there is limited information on how polymorphisms in cytokine genes influence oxidative stress in SCD patients. The study aimed to determine the effect of Interleukin gene (IL-10) and Tumor Necrosis Factor (TNF) polymorphisms on oxidative stress and cytokine levels in SCD patients from Mulago hospital.
View Article and Find Full Text PDFThromb J
September 2025
C-Care International Hospital Kampala, Plot 4686 Barnabas Road, Kampala, Uganda.
Background: Majority of people with "kissing carotids", an anatomical variation of the cervical carotid arteries showing tortuosity, kinking or coiling and coming in proximity at the midline are asymptomatic. Less than 1% of the general population have Protein S Deficiency. This report discusses a rare case of a young female with co-existent Protein S deficiency and kissing carotids, who presented with sequential thrombosis in both arterial and venous cerebral circulation systems and further discusses potential mechanisms of arterial thrombosis in Protein S deficiency and medical options for secondary stroke prophylaxis in this context.
View Article and Find Full Text PDFPLoS Negl Trop Dis
September 2025
School of Biodiversity, One Health and Veterinary Medicine, University of Glasgow, Glasgow, United Kingdom.
Direct morbidity assessments are rarely included in monitoring and evaluation of Schistosoma mansoni mass drug administration programmes. This is despite morbidity reduction being the leading objective of control and elimination as a public health problem in the World Health Organization (WHO) targets. Instead, the number of eggs-per-gram (EPG) of faeces are used as a morbidity proxy.
View Article and Find Full Text PDF